<DOC>
	<DOC>NCT00491114</DOC>
	<brief_summary>This is a phase II study where chemotherapy (gemcitabine) is given into the urinary bladder.</brief_summary>
	<brief_title>Intravesical Chemotherapy Treatment of Superficial Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>Superficial bladder cancer No prior chemotherapy Grade 3 tumors Papillary tumors invading connective tissue Significant urologic disease, possible interfering with intravesical therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>